A new method is described for obtaining a 3-D reconstruction of a bioluminescent light source distribution inside a living animal subject, from multispectral images of the surface light emission acquired on charge-coupled device (CCD) camera. The method uses the 3-D surface topography of the animal, which is obtained from a structured light illumination technique. The forward model of photon transport is based on the diffusion approximation in homogeneous tissue with a local planar boundary approximation for each mesh element, allowing rapid calculation of the forward Green's function kernel. Absorption and scattering properties of tissue are measured a priori as input to the algorithm. By using multispectral images, 3-D reconstructions of luminescent sources can be derived from images acquired from only a single view. As a demonstration, the reconstruction technique is applied to determine the location and brightness of a source embedded in a homogeneous phantom subject in the shape of a mouse. The technique is then evaluated with real mouse models in which calibrated sources are implanted at known locations within living tissue. Finally, reconstructions are demonstrated in a PC3M-luc (prostate tumor line) metastatic tumor model in nude mice.
Quite recently Cerenkov luminescence imaging (CLI) has been introduced as a novel pre-clinical imaging for the in vivo imaging of small animals such as mice. The CLI method is based on the detection of Cerenkov radiation (CR) generated by beta particles as they travel into the animal tissues with an energy such that Cerenkov emission condition is satisfied. This paper describes an image reconstruction method called multi spectral diffuse Cerenkov luminescence tomography (msCLT) in order to obtain 3D images from the detection of CR. The multispectral approach is based on a set of 2D planar images acquired using a number of narrow bandpass filters, and the distinctive information content at each wavelength is used in the 3D image reconstruction process. The proposed msCLT method was tested both in vitro and in vivo using 32P-ATP and all the images were acquired by using the IVIS 200 small animal optical imager (Caliper Life Sciences, Alameda USA). Source depth estimation and spatial resolution measurements were performed using a small capillary source placed between several slices of chicken breast. The theoretical Cerenkov emission spectrum and optical properties of chicken breast were used in the modelling of photon propagation. In vivo imaging was performed by injecting control nude mice with 10 MBq of 32P-ATP and the 3D tracer bio-distribution was reconstructed. Whole body MRI was acquired to provide an anatomical localization of the Cerenkov emission. The spatial resolution obtained from the msCLT reconstructed images of the capillary source showed that the FWHM is about 1.5 mm for a 6 mm depth. Co-registered MRI images showed that the Cerenkov emission regions matches fairly well with anatomical regions, such as the brain, heart and abdomen. Ex vivo imaging of the different organs such as intestine, brain, heart and ribs further confirms these findings. We conclude that in vivo 3D bio-distribution of a pure beta-minus emitting radiopharmaceutical such as 32P-ATP can be obtained using the msCLT reconstruction approach.
S U M M A R YThe resolution of the 3-D density structure in the Earth's deep interior has long eluded geoscientists. High-quality data from digital seismic instruments emplaced this decade have renewed interest in the measurement of low-frequency Earth normal modes with the goal of extracting heterogeneous density structure. Here we perform a series of synthetic experiments aimed at investigating the resolution of lateral variations in the mantle from normal-mode spectral data. Contamination effects between seismic velocities and density are examined in two ways: (1) by using resolution matrices computed from data kernels and (2) by inverting synthetic spectra computed from realistic input Earth models. The first type of experiment assumes that the non-linearity of the inverse problem is weak. No such assumptions are necessary in the second type of tests which, nevertheless concur in their results with the former. These synthetic tests indicate that density structure retrieved from presently available normal-mode data is not reliable. Contamination of seismic velocity structure into the density model space produces patterns that resemble those obtained from inversions of real data. The resulting density models appear to be dependent on a combination of the starting velocity models and the model parametrization.
General circulation models (GCMs) are extensively used to estimate the influence of clouds on the global energy budget and other aspects of climate. Because radiative transfer computations involved in GCMs are costly, it is typical to consider only absorption but not scattering by clouds in longwave (LW) spectral bands. In this study, the flux and heating rate biases due to neglecting the scattering of LW radiation by clouds are quantified by using advanced cloud optical property models, and satellite data from Cloud‐Aerosol Lidar and Infrared Pathfinder Satellite Observation (CALIPSO), CloudSat, Clouds and the Earth's Radiant Energy System (CERES), and Moderate Resolution Imaging Spectrometer (MODIS) merged products (CCCM). From the products, information about the atmosphere and clouds (microphysical and buck optical properties, and top and base heights) is used to simulate fluxes and heating rates. One‐year global simulations for 2010 show that the LW scattering decreases top‐of‐atmosphere (TOA) upward flux and increases surface downward flux by 2.6 and 1.2 W/m2, respectively, or approximately 10% and 5% of the TOA and surface LW cloud radiative effect, respectively. Regional TOA upward flux biases are as much as 5% of global averaged outgoing longwave radiation (OLR). LW scattering causes approximately 0.018 K/d cooling at the tropopause and about 0.028 K/d heating at the surface. Furthermore, over 40% of the total OLR bias for ice clouds is observed in 350–500 cm−1. Overall, the radiative effects associated with neglecting LW scattering are comparable to the counterpart due to doubling atmospheric CO2 under clear‐sky conditions.
Methane also heats the climate system by absorbing sunlight, and the absorption is maximized over bright clouds and deserts.
Surface longwave emissivity can be less than unity and vary significantly with frequency. However, most climate models still assume a blackbody surface in the longwave (LW) radiation scheme of their atmosphere models. This study incorporates realistic surface spectral emissivity into the atmospheric component of the Community Earth System Model (CESM), version 1.1.1, and evaluates its impact on simulated climate. By ensuring consistency of the broadband surface longwave flux across different components of the CESM, the top-of-the-atmosphere (TOA) energy balance in the modified model can be attained without retuning the model. Inclusion of surface spectral emissivity, however, leads to a decrease of net upward longwave flux at the surface and a comparable increase of latent heat flux. Global-mean surface temperature difference between the modified and standard CESM simulation is 0.20 K for the fully coupled run and 0.45 K for the slabocean run. Noticeable surface temperature differences between the modified and standard CESM simulations are seen over the Sahara Desert and polar regions. Accordingly, the climatological mean sea ice fraction in the modified CESM simulation can be less than that in the standard CESM simulation by as much as 0.1 in some regions. When spectral emissivities of sea ice and open ocean surfaces are considered, the broadband LW sea ice emissivity feedback is estimated to be 20.003 W m 22 K 21, assuming flat ice emissivity as sea ice emissivity, and 0.002 W m 22 K 21 , assuming coarse snow emissivity as sea ice emissivity, which are two orders of magnitude smaller than the surface albedo feedback.
ObjectiveBrown adipose tissue (BAT), a specialized tissue for thermogenesis, plays important roles for metabolism and energy expenditure. Recent studies validated BAT’s presence in human adults, making it an important re-emerging target for various pathologies. During this validation, PET images with 18F-FDG showed significant uptake of 18F-FDG by BAT under certain conditions. Here, we demonstrated that Cerenkov luminescence imaging (CLI) using 18F-FDG could be utilized for in vivo optical imaging of BAT in mice.MethodsMice were injected with 18F-FDG and imaged 60 minutes later with open filter and 2 minute acquisition. In vivo activation of BAT was performed by norepinephrine and cold treatment under isoflurane or ketamine anesthesia. Spectral unmixing and 3D imaging reconstruction were conducted with multiple-filter CLI images.Results1) It was feasible to use CLI with 18F-FDG to image interscapular BAT in mice, with the majority of the signal (>85%) at the interscapular site originating from BAT; 2) The method was reliable because excellent correlations between in vivo CLI, ex vivo CLI, and ex vivo radioactivity were observed; 3) CLI could be used for monitoring BAT activation under different conditions; 4) CLI signals from the group under short-term isoflurane anesthesia were significantly higher than that from the group under long-term anesthesia; 5) The CLI spectrum of 18F-FDG with a peak at 640 nm in BAT after spectral unmixing reflected the actual context of BAT; 6) Finally 3D reconstruction images showed excellent correlation between the source of the light signal and the location and physical shape of BAT.ConclusionCLI with 18F-FDG is a feasible and reliable method for imaging BAT in mice. Compared to PET imaging, CLI is significantly cheaper, faster for 2D planar imaging and easier to use. We believe that this method could be used as an important tool for researchers investigating BAT.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.